We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · June 28, 2021

Abnormal Uterine Bleeding Following the Use of Apixaban and Rivaroxaban to Treat Venous Thromboembolism

Thrombosis Research


Additional Info

Thrombosis Research
Incidence of Abnormal Uterine Bleeding in a Multicenter Implementation Study Using Apixaban and Rivaroxaban to Treat Venous Thromboembolism
Thromb. Res. 2021 May 26;[EPub Ahead of Print], J Pagenhardt, I Hayward, B Dilcher, K Quedado, J Kline

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading